Cargando…

Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality

BACKGROUND AND OBJECTIVE: The definition of pre-capillary pulmonary hypertension (PH) has been modified, with lowering of the mean pulmonary arterial pressure (mPAP) threshold from 25 to 20 mmHg and addition of a mandatory criterion of pulmonary vascular resistance (PVR) ≥ 2 Wood units (WU). Our obj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puigrenier, Sébastien, Giovannelli, Jonathan, Lamblin, Nicolas, De Groote, Pascal, Fertin, Marie, Bervar, Jean-François, Lamer, Antoine, Edmé, Jean-Louis, Balquet, Marie-Hélène, Sobanski, Vincent, Launay, David, Hachulla, Éric, Sanges, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571468/ https://www.ncbi.nlm.nih.gov/pubmed/36243869 http://dx.doi.org/10.1186/s12931-022-02205-4

Ejemplares similares

Factors associated with the 6-minute walk distance in patients with systemic sclerosis
por: Sanges, Sébastien, et al.
Publicado: (2017)

Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis
por: Sivova, Nadia, et al.
Publicado: (2013)

Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2019)

Pulmonary hypertension in systemic sclerosis: different phenotypes
por: Launay, David, et al.
Publicado: (2017)

Subacute right heart failure revealing three simultaneous causes of post‐embolic pulmonary hypertension in metastatic dissemination of breast cancer
por: Vincent, Flavien, et al.
Publicado: (2016)

Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2022)

Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues
por: Berthelot, Emmanuelle, et al.
Publicado: (2018)

Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis
por: Speca, Silvia, et al.
Publicado: (2023)

Assessment of lung hyperinflation in occupational chronic obstructive pulmonary disease: a multicentric cross-sectional study
por: de Broucker, Virginie, et al.
Publicado: (2023)

Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature
por: Sanges, Sébastien, et al.
Publicado: (2016)

Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis
por: Chikhoune, Liticia, et al.
Publicado: (2022)

Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice
por: Bauters, Christophe, et al.
Publicado: (2017)

Impact of the updated hemodynamic definitions on diagnosis rates of pulmonary hypertension
por: Tanyeri, Seda, et al.
Publicado: (2020)

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients
por: Hachulla, A-L, et al.
Publicado: (2009)

B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis
por: Sanges, Sébastien, et al.
Publicado: (2017)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?
por: Ducrocq, Quentin, et al.
Publicado: (2023)

Vorticity for the assessment of pulmonary vascular hemodynamics in pulmonary arterial hypertension
por: Honeyman, Alexander, et al.
Publicado: (2014)

Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension
por: Barańska-Pawełczak, Karolina, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables
por: Pausch, Christine, et al.
Publicado: (2023)

Simple gene signature to assess murine fibroblast polarization
por: Ledoult, Emmanuel, et al.
Publicado: (2022)

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
por: Sobanski, Vincent, et al.
Publicado: (2019)

How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
por: Sarı, Alper, et al.
Publicado: (2020)

Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study
por: Karia, Nina, et al.
Publicado: (2023)

Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis
por: Sanges, S., et al.
Publicado: (2020)

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
por: Launay, David, et al.
Publicado: (2013)

Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis
por: Sobanski, Vincent, et al.
Publicado: (2018)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition
por: Mandoli, Giulia Elena, et al.
Publicado: (2023)

Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era
por: Zelt, Jason G.E., et al.
Publicado: (2022)

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease
por: Portillo, Karina, et al.
Publicado: (2015)

Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023)

Activités de recours et de recherche d’un service de Médecine Interne : une place pour la télémédecine, au-delà de la pandémie COVID-19 ?
por: Ducrocq, Q., et al.
Publicado: (2021)

High-intensity interval training and pulmonary hemodynamics in COPD with hypoxemia
por: Aakerøy, Lars, et al.
Publicado: (2021)

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease [Corrigendum]
Publicado: (2015)

Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability
por: Revuz, Sabine, et al.
Publicado: (2017)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function
por: Lang, Irene M, et al.
Publicado: (2023)

Effect of Obesity on Pulmonary Vascular Hemodynamics
por: Duran, Mustafa, et al.
Publicado: (2020)

Clinical Characteristics and Outcome of Patients with Infective Endocarditis Diagnosed in a Department of Internal Medicine
por: Kreitmann, Louis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0eaerc20649vvd1q91bsjpvv8a